Aspirin for recurrence prevention in bipolar disorder-Promising, yet clinically understudied?Haarman, B. C. M., de Boer, M. K., van der Gaag, C. M., Burger, H., Nolen, W. A. & Schoevers, R. A., Feb-2019, In : Bipolar Disorders. 21, 1, p. 13-15 3 p.
Research output: Contribution to journal › Editorial › Academic › peer-review
Current available maintenance pharmacotherapy for bipolar disorder (BD) leaves ample room for improvement. Up to 50% of patients with BD do not respond adequately to available treatments and still suffer from manic and/or depressive episodes. In this perspective article, we will give an overview of the neuropharmacodynamics of (low-dose) aspirin, reflect on the published clinical studies and argue that aspirin is a promising, yet understudied option for recurrence prevention This article is protected by copyright. All rights reserved.
|Number of pages||3|
|Early online date||25-Nov-2018|
|Publication status||Published - Feb-2019|